The purpose of this summary is to evaluate the efficacy and safety of R89674 0.025% ophthalmic solution compared with placebo or an active control in subjects with seasonal allergic conjunctivitis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
365
Unnamed facility
Louisville, Kentucky, United States
Unnamed facility
North Andover, Massachusetts, United States
Unnamed facility
Creve Coeur, Missouri, United States
Unnamed facility
Charlotte, North Carolina, United States
Ocular itching and redness scores at defined timepoints
QOL, severity of chemosis & redness, ocular itching and redness scores at defined timepoints
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Philadelphia, Pennsylvania, United States
Unnamed facility
Memphis, Tennessee, United States